Mark G. Lebwohl, MD, Dean for Clinical Therapeutics for the Department of Dermatology at the Icahn School of Medicine at Mount Sinai was presented ASA's Lifetime Achievement Award for his distinguished four-decade career in dermatology.

Mark G. Lebwohl, MD and LEO Pharma received honors at  the American Skin Association’s (ASA) annual Spring Gala, 

"We were proud to honor Dr. Mark Lebwohl and LEO Pharma for their dedication to the field of dermatology. Both honorees share in ASA's crucial mission of finding cures for skin diseases,” says Howard P. Milstein, Chairman of ASA, in a news release.

This year, awards were presented to the following:

Mark G. Lebwohl, MD, Dean for Clinical Therapeutics for the Department of Dermatology at the Icahn School of Medicine at Mount Sinai was presented ASA's Lifetime Achievement Award for his distinguished four-decade career in dermatology. The award was presented by ASA President, David A. Norris, MD, who applauded Dr. Lebwohl's continuing dedication to inspiring, educating and mentoring the next generation of dermatologists. Dr. Lebwohl is Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology. He is an internationally respected physician, scientist, and administrative leader, as well as a pioneer in immuno-dermatology. He is also an accomplished author of over 700 publications and is co-author of the leading book on dermatologic therapy, Treatment of Skin Disease, now in its 6th edition.

Global pharmaceutical leader LEO Pharma received the 2023 Distinguished Corporate Leadership Award. The award was presented by Mark G. Lebwohl, MD and was accepted by LEO Pharma's Vice President and Global Head of Medical Affairs, Dr. Judit Nyirady. LEO has a long and rich history in the pharmaceutical industry and was founded in Copenhagen 115 years ago. Dr. Lebwohl shared that the company is dedicated to advancing the standard of care for the benefit of patients, their caregivers, and the world. LEO's stated values of integrity, customer focus, innovation, passion and adaptability reflect the way their people strive to increase the quality of life for patients.

President of ASA, Dr. David A. Norris, says "I congratulate Dr. Lebwohl and LEO Pharma on these well-deserved honors! We look forward to continuing to build strong partnerships with physicians like Dr. Lebwohl and organizations like LEO Pharma as we work together to provide hope to patients and their families."